GeneHealth - Your precision medicine

Haverhill Fever

Disease Details

Family Health Simplified

Buy Membership

Description: Haverhill fever, also known as rat-bite fever, is an infectious disease caused by the bacteria Streptobacillus moniliformis, often resulting from contact with rodents or contaminated food and water.
Type: Haverhill fever is a bacterial infection. It is not genetically transmitted.
Signs And Symptoms: Haverhill fever, also known as rat-bite fever, is caused by the bacterium Streptobacillus moniliformis. Common signs and symptoms include:

- Fever
- Chills
- Headache
- Muscle pain (myalgia)
- Joint pain (arthralgia)
- Rash, typically on the hands and feet
- Vomiting

Symptoms typically appear within 3 to 10 days after exposure. If left untreated, the disease can lead to severe complications, so prompt medical attention is recommended. Nan is not a recognized symptom or aspect of haverhill fever.
Prognosis: Prognosis for Haverhill fever, which is caused by the bacterium Streptobacillus moniliformis, is generally good with appropriate antibiotic treatment. Most patients respond well to antibiotics such as penicillin or doxycycline, leading to a full recovery. Without treatment, serious complications can occur, including arthritis, endocarditis, or abscess formation. Therefore, prompt medical attention and proper antibiotic therapy are crucial for a favorable outcome.
Onset: Haverhill fever, also known as rat-bite fever, typically has an onset of symptoms within 3 to 10 days after exposure, though it can be as long as three weeks.
Prevalence: Haverhill fever, also known as rat-bite fever, is relatively rare. Precise prevalence rates are not well-documented, but cases typically occur in areas with poor sanitation and close contact with rodents. The disease is most commonly reported in Japan, the United States, and some parts of Europe.
Epidemiology: Haverhill fever, also known as rat-bite fever, is a systemic illness caused by the bacterium Streptobacillus moniliformis. It is relatively rare and occurs worldwide, though most cases are reported in the United States and Japan. The disease is primarily associated with exposure to rodents or consumption of food or water contaminated with rodent excreta. It is more common in urban areas where rodent populations are high. Infections may also occur in individuals who keep rodents as pets or work in settings where contact with rodents is frequent.
Intractability: Haverhill fever, also known as rat-bite fever when contracted through consumption of contaminated food or water, is not generally considered intractable. It can be effectively treated with antibiotics, particularly penicillin or doxycycline. Early diagnosis and proper medical treatment typically lead to successful recovery.
Disease Severity: Haverhill fever, also known as rat-bite fever, is caused by the bacterium Streptobacillus moniliformis. The disease can range from mild to moderate in severity. If untreated, it can lead to serious complications, but with appropriate antibiotic treatment, the prognosis is generally good.
Healthcare Professionals: Disease Ontology ID - DOID:13238
Pathophysiology: Haverhill fever, also known as rat-bite fever, is caused by the bacterium Streptobacillus moniliformis. The disease usually follows a rat bite or scratch, or ingestion of food or water contaminated with the bacterium.

**Pathophysiology:**
The bacteria enter the bloodstream either through a break in the skin or via ingestion. Once in the bloodstream, the bacteria can disseminate to various organs, leading to systemic symptoms. The infection activates the immune system, causing fever and inflammation. The bacteria's presence in the blood (bacteremia) triggers a widespread immune response, which can result in symptoms such as fever, chills, rash, and arthritis. If not treated, complications like endocarditis, meningitis, and abscess formation can occur.

The exact molecular mechanisms by which Streptobacillus moniliformis causes disease remain less clearly defined compared to other pathogens, but it is understood to provoke an inflammatory response that leads to the clinical manifestations of the disease. Prompt antibiotic treatment is essential to prevent severe complications and promote recovery.
Carrier Status: Haverhill fever, also known as rat-bite fever, is typically caused by the bacterium Streptobacillus moniliformis. Carrier status for this disease often involves rodents, particularly rats, which can carry the bacterium without showing symptoms. Humans usually acquire the infection through bites or scratches from these animals or by ingesting food or water contaminated with their secretions. There are no known chronic carriers among humans.
Mechanism: Although the specific form of pathogenesis is still a subject of ongoing research, the bacteria has been observed to result in morphological symptoms that are atypical of bacterial infection. Autopsy of the victims vividly exhibit erythrophagocytosis, hepatosplenomegaly, interstitial pneumonia, and lymph node sinus hyperplasia. In addition, Myocarditis and Endocarditis have also been demonstrated in such patients. Synovial and serosal surfaces may be more suited for the growth of the bacteria within the body. Furthermore, leukocytoclastic vasculitis has been observed in the skin lesions.
Treatment: The bacteria are susceptible to a number of antibiotics. They are: cephalosporins, carbapenems, aztreonam, clindamycin, erythromycin, nitrofurantoin, bacitracin, doxycycline, tetracycline, teicoplanin, and vancomycin. However, the data suggests that treatment with erythromycin can be less efficient. Intravenous penicillin G (400000–600000 IU/day) should be administered for 7 days and then a dosage of oral penicillin must be prescribed. Children should receive a much lesser dose: 20,000–50,000 IU, per kg of body weight per day. However, if somebody is allergic to penicillin, streptomycin and tetracycline can be administered as they have also been observed to provide efficacious results. In case of complications such as endocarditis, a combination therapy with both intravenous penicillin G and streptomycin or gentamicin is necessary.
Compassionate Use Treatment: Haverhill fever, also known as rat-bite fever, is generally treated with antibiotics such as penicillin or doxycycline. Compassionate use treatment, off-label, or experimental treatments are not typically indicated for this condition because the standard antibiotic therapy is usually effective. However, in cases of severe allergy to standard antibiotics, alternative treatments may be considered under medical supervision.

If there are specific cases where standard treatments aren't effective or available, healthcare providers might consider investigational therapies or refer to compassionate use programs that grant access to experimental drugs for patients with no other treatment options, although this is rare for Haverhill fever. Always consult a healthcare professional for the most appropriate treatment plan.
Lifestyle Recommendations: Haverhill fever, also known as rat-bite fever, is caused by the bacterium Streptobacillus moniliformis, typically through contact with rodents or consumption of contaminated food or water.

**Lifestyle Recommendations:**
1. **Avoid Rodent Contact**: Minimize exposure to rodents by keeping living and working areas clean and free of rodents. Use traps and rodent-proof containers for food storage.
2. **Personal Hygiene**: Wash hands thoroughly with soap and water after handling animals, their bedding, or potentially contaminated items.
3. **Safe Food Practices**: Consume only well-cooked food and ensure water is from a safe source to prevent ingestion of contaminated substances.
4. **Protective Gear**: Wear gloves and other protective clothing if handling rodents or working in environments likely to be contaminated.
5. **Prompt Medical Attention**: Seek medical advice immediately if bitten by a rodent or if symptoms such as fever, rash, or joint pain appear after potential exposure.

By following these guidelines, the risk of contracting Haverhill fever can be significantly reduced.
Medication: Haverhill fever, also known as rat-bite fever, is commonly caused by the bacterium Streptobacillus moniliformis. The primary treatment for this infection is antibiotics. Penicillin is the most commonly prescribed antibiotic for Haverhill fever. In cases where a person is allergic to penicillin, alternative antibiotics such as doxycycline or tetracycline can be used. It is important for individuals to complete the full course of antibiotics as prescribed by their healthcare provider to ensure effective treatment and reduce the risk of complications.
Repurposable Drugs: Haverhill fever, also known as rat-bite fever, is typically caused by the bacterium Streptobacillus moniliformis. Standard treatment involves antibiotics, primarily penicillin or tetracycline. There are currently no widely recognized repurposable drugs specifically identified for Haverhill fever beyond the standard antibiotics used.
Metabolites: Haverhill fever, also known as rat-bite fever, is primarily caused by the bacterium Streptobacillus moniliformis. Information specifically about the metabolites involved in Haverhill fever is limited. In general, bacterial infections can lead to various metabolic changes in the host, but specific metabolites unique to this condition are not well-documented or characterized in clinical literature.
Nutraceuticals: Haverhill fever, also known as rat-bite fever when contracted through ingestion, does not have specific nutraceutical treatments. Management typically involves antibiotic therapy, such as penicillin or doxycycline. Nutraceuticals, which are products derived from food sources with extra health benefits in addition to their basic nutritional value, have not been established as a treatment for Haverhill fever. Proper medical care and antibiotic treatment are essential for recovery.
Peptides: Haverhill fever, also known as rat-bite fever (RBF), caused by the bacterium Streptobacillus moniliformis, does not have a well-defined relationship to peptides and nanotechnology (nan). The primary focus in clinical practice and research regarding Haverhill fever involves the bacterium, its transmission, symptoms, diagnosis, and treatment. Peptides are not specifically highlighted in relation to this condition, and nanotechnology does not play a direct role in its current standard management or treatment.